Intensity Therapeutics Inc (INTS)

Apr 03, 2025

IntercontinentalExchange price target lowered to $230 from $237 at BofA - Yahoo Finance

Apr 03, 2025

Apr 03, 2025

Has Cencora, Inc. (COR) Outpaced Other Medical Stocks This Year? - Yahoo Finance

Apr 03, 2025

Apr 02, 2025

Soft Tissue Sarcoma Treatment Market Size in 7MM is expected - openPR.com

Apr 02, 2025

Apr 02, 2025

Insiders At Cencora Sold US$16m In Stock, Alluding To Potential Weakness - Yahoo Finance

Apr 02, 2025

Mar 25, 2025

Leading Factor Driving the Burkitt Lymphoma Therapeutics Market in 2025: Impact Of Rising HIV Incidence On ... - WhaTech

Mar 25, 2025

Mar 24, 2025

12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga

Mar 24, 2025

Mar 20, 2025

12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga

Mar 20, 2025

Mar 19, 2025

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

Mar 19, 2025

Mar 19, 2025

Soft Tissue Sarcoma Clinical Pipeline | 70+ Companies Driving Innovation in Treatment - openPR

Mar 19, 2025

Mar 19, 2025

Benchmark maintains Speculative Buy on Intensity Therapeutics By Investing.com - Investing.com South Africa

Mar 19, 2025

Mar 19, 2025

Benchmark maintains Speculative Buy on Intensity Therapeutics - Investing.com

Mar 19, 2025

Mar 18, 2025

Soft Tissue Neoplasms Treatment Market Size in 7MM is expected - openPR

Mar 18, 2025

Mar 13, 2025

INTENSITY THERAPEUTICS Earnings Results: $INTS Reports Quarterly Earnings - Nasdaq

Mar 13, 2025

Mar 13, 2025

Small Number of Acne Products Recalled for Problematic Levels of Benzene - 69News WFMZ-TV

Mar 13, 2025

Mar 13, 2025

Intensity Therapeutics Reports 2024 Year End Financial Results and Provides Corporate Update - PR Newswire

Mar 13, 2025

Mar 13, 2025

Intensity Therapeutics Doubles R&D Investment as Cancer Trials Gain Momentum - Stock Titan

Mar 13, 2025

Mar 07, 2025

Tempest Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:TPST - Benzinga

Mar 07, 2025

Mar 05, 2025

Bile Duct Neoplasms Treatment Market Size Report 2032 | Taewoong - openPR.com

Mar 05, 2025

Feb 25, 2025

Alpheus Medical Publishes Promising Early Clinical Results of Sonodynamic Therapy for the Treatment of Newly Diagnosed Glioblastomas - Yahoo Finance

Feb 25, 2025

Feb 21, 2025

Equillium (NASDAQ:EQ) Stock Quotes, Forecast and News Summary - Benzinga

Feb 21, 2025

Feb 13, 2025

AMC Networks (AMCX) To Report Earnings Tomorrow: Here Is What To Expect - The Globe and Mail

Feb 13, 2025

Feb 06, 2025

Grafapex Approved for Reduced-Intensity Stem Cell Transplants in AML and MDS Patients - Managed Healthcare Executive

Feb 06, 2025

Feb 03, 2025

Intensity Infrastucture Partners Launches Open Season for New Natural Gas Transmission Pipeline to Serve the Bakken Region - Yahoo Finance

Feb 03, 2025

Feb 03, 2025

Clinical Trials News Live Feed - StockTitan

Feb 03, 2025

Feb 03, 2025

Xylem (XYL) To Report Earnings Tomorrow: Here Is What To Expect - The Globe and Mail

Feb 03, 2025

Jan 28, 2025

Drug Monitoring Committee Authorizes Continuation of Intensity T - GuruFocus.com

Jan 28, 2025

Jan 28, 2025

Intensity Therapeutics' sarcoma trial proceeds after review By Investing.com - Investing.com Canada

Jan 28, 2025

Jan 28, 2025

Intensity Therapeutics' sarcoma trial proceeds after review - Investing.com India

Jan 28, 2025

Jan 28, 2025

Drug Monitoring Committee Authorizes Continuation of Intensity Therapeutics' Ongoing Global Randomized Phase 3 Sarcoma Trial ("INVINCIBLE-3 Study") Following Periodic Review - Nasdaq

Jan 28, 2025

Jan 28, 2025

High Intensity Focused Ultrasound Market Forecast and Company Analysis 2025-2033 Featuring Koninklijke Philips, Johnson & Johnson, Hitachi, General Electrics, Medtronic, Stryker, EDAP TMS, Theraclion - Yahoo Finance

Jan 28, 2025

Jan 23, 2025

vTv Therapeutics (NASDAQ:VTVT) Stock Quotes, Forecast and News Summary - Benzinga

Jan 23, 2025

Jan 21, 2025

Soft Tissue Sarcoma Market Poised for Significant Growth from - openPR

Jan 21, 2025

Jan 15, 2025

Soft Tissue Sarcoma Pipeline Review 2024: Clinical Trials - openPR

Jan 15, 2025

Jan 13, 2025

Alliance Global Partners Initiates Coverage of Intensity Therapeutics (INTS) with Buy Recommendation - MSN

Jan 13, 2025